Becton, Dickinson & Co (NYSE:BDX) on 11/19/2018 declared a dividend of $ 0.7700 per share payable on December 31, 2018 to shareholders of record as of December 10, 2018. Dividend amount recorded is an increase of $ 0.02 from last dividend Paid.

Becton, Dickinson & Co (NYSE:BDX) has paid dividends since 1926, has a current dividend yield of 1.2516763210% and has increased its dividends for 6 successive years.

Becton, Dickinson & Co's market cap is $ 65,839,473,480 and has a PE ratio of 106.06. The stock price closed yesterday at $ 246.07 and has a 52 week low/high of $ 209.91 and $ 265.87.

Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s operations consist of two business segments: BD Medical and BD Life Sciences. BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers.

For more information on Becton, Dickinson & Co click here.